Taube, MārisLesiņa, Alise Alma2025-01-272025-01-272024Taube, M & Lesiņa, A A 2024, 'Case report : Development of anxiety symptoms after receiving the Pfizer-BioNTech (BNT162b2) COVID-19 vaccine: a case series', Frontiers in Psychiatry, vol. 15, 1514428. https://doi.org/10.3389/fpsyt.2024.15144281664-0640Mendeley: 27df56ae-8ce1-366f-b271-2cd66feccc3bunpaywall: 10.3389/fpsyt.2024.1514428https://dspace.rsu.lv/jspui/handle/123456789/17039Publisher Copyright: Copyright © 2025 Taube and Lesiņa.Severe acute respiratory sindrome - Coronavirus - 2 (SARS-CoV-2) (Coronavirus disease - 19 (COVID-19)) infection can result in long-term health consequences, such as long COVID. The clinical manifestations of long COVID include depression, anxiety, brain fog with cognitive dysfunction, memory issues, and fatigue. However, the links between vaccination and psychiatric disorders have been less studied. This article describes three patients who reported anxiety after receiving a complete course of the Pfizer-BioNTech BNT162b2 vaccine. It is important to explore the relationship between anxiety, other mental health disorders, and COVID-19 vaccination, as well as to investigate potential pathogenetic mechanisms.292064enginfo:eu-repo/semantics/openAccessCOVID-19 vaccinesSARS-CoV-2 vaccineBioNTech162 vaccineanxietycase reports3.3 Health sciences3.5 Other medical sciences3.2 Clinical medicine1.1. Scientific article indexed in Web of Science and/or Scopus databaseSDG 3 - Good Health and Well-being/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article10.3389/fpsyt.2024.1514428http://www.scopus.com/inward/record.url?scp=85216742691&partnerID=8YFLogxK